theory clinical_39_2
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Has :: "entity ⇒ entity ⇒ bool"
  TTKInhibitor :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Block :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"
  Effects :: "entity ⇒ bool"
  Of :: "entity ⇒ entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  Make :: "event ⇒ bool"
  EffectiveIn :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: This patient has an activating mutation in CTNNB. *)
axiomatization where
  explanation_1: "∃x y z. Patient x ∧ Mutation y ∧ Activating y ∧ In y z ∧ Has x y"

(* Explanation 2: TTK inhibitors block the activity of CTNNB. *)
axiomatization where
  explanation_2: "∃x y z e. TTKInhibitor x ∧ Activity y ∧ In y z ∧ Block e ∧ Agent e x ∧ PatientEvent e y"

(* Explanation 3: Blocking the activity of CTNNB1 can reduce the effects of activating mutations in CTNNB. *)
axiomatization where
  explanation_3: "∀x y z w e1 e2. Activity x ∧ In x y ∧ Mutation z ∧ Activating z ∧ In z w ∧ Effects w ∧ Of w z ∧ Block e1 ∧ PatientEvent e1 x ⟶ (Reduce e2 ∧ Agent e2 x ∧ PatientEvent e2 w)"

(* Explanation 4: Reducing the effects of activating mutations in CTNNB1 can potentially make TTK inhibitors effective in such patients. *)
axiomatization where
  explanation_4: "∀x y z w e1 e2 e3. Mutation x ∧ Activating x ∧ In x y ∧ Effects z ∧ Of z x ∧ TTKInhibitor w ∧ Patient y ∧ Reduce e1 ∧ PatientEvent e1 z ⟶ (Make e2 ∧ Agent e2 w ∧ PatientEvent e2 y ∧ EffectiveIn w y)"

theorem hypothesis:
  assumes asm: "TTKInhibitor x ∧ Patient y"
  (* Hypothesis: A TTK Inhibitor may be effective in this patient. *)
  shows "∃x y. TTKInhibitor x ∧ Patient y ∧ EffectiveIn x y"
proof -
  (* From the premise, we have known information about TTKInhibitor and Patient. *)
  from asm have "TTKInhibitor x ∧ Patient y" by simp
  (* Explanation 1 provides that a patient has an activating mutation in CTNNB. *)
  from explanation_1 obtain a b c where "Patient a ∧ Mutation b ∧ Activating b ∧ In b c ∧ Has a b" by blast
  (* Explanation 2 provides that TTK inhibitors block the activity of CTNNB. *)
  from explanation_2 obtain d e f g where "TTKInhibitor d ∧ Activity e ∧ In e f ∧ Block g ∧ Agent g d ∧ PatientEvent g e" by blast
  (* Explanation 3 states that blocking the activity of CTNNB1 can reduce the effects of activating mutations in CTNNB. *)
  from explanation_3 have "∀x y z w e1 e2. Activity x ∧ In x y ∧ Mutation z ∧ Activating z ∧ In z w ∧ Effects w ∧ Of w z ∧ Block e1 ∧ PatientEvent e1 x ⟶ (Reduce e2 ∧ Agent e2 x ∧ PatientEvent e2 w)" by fastforce
  (* Explanation 4 states that reducing the effects of activating mutations in CTNNB1 can potentially make TTK inhibitors effective in such patients. *)
  from explanation_4 have "∀x y z w e1 e2 e3. Mutation x ∧ Activating x ∧ In x y ∧ Effects z ∧ Of z x ∧ TTKInhibitor w ∧ Patient y ∧ Reduce e1 ∧ PatientEvent e1 z ⟶ (Make e2 ∧ Agent e2 w ∧ PatientEvent e2 y ∧ EffectiveIn w y)" by blast
  (* Using the logical relations and derived implications, we can infer that TTK inhibitors can be effective. *)
  from `TTKInhibitor x ∧ Patient y` and `Patient a ∧ Mutation b ∧ Activating b ∧ In b c ∧ Has a b` and `TTKInhibitor d ∧ Activity e ∧ In e f ∧ Block g ∧ Agent g d ∧ PatientEvent g e` 
  have "EffectiveIn x y" sledgehammer
  then show ?thesis <ATP>
qed

end
